Investing with Purpose
Investing with Purpose: Aligning Financial Returns and Social Impact in Health Equity Initiatives Squire Servance Squire Servance Founder & Managing Partner @ Syridex Bio | Investing in Medicines & Therapies…
Read More Addressing the Social and Political Determinants of Health
Addressing the Social and Political Determinants of Health Requires Broad, Unified Action – and Immediate Focus By Squire Servance, Founder and Managing Partner of Syridex Bio and Michellene Davis, Esq.,…
Read More Syridex Bio Selected by NJEDA
Life sciences impact investment firm receives allocation to support businesses advancing health equity, targeting therapies for diseases that disproportionately affect underserved populations. NEW YORK–(BUSINESS WIRE)–Syridex Bio (“Syridex”), an impact-driven, life…
Read More Managing Partner at Syridex Bio Joins The Wistar Institute Board
PHILADELPHIA — (MARCH, 30, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Squire Servance, founder and managing…
Read More Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity
Press release Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity Impact investment firm focuses on investing in therapies for diseases that disproportionately affect underserved populations, including…
Read More Social Justice in Healthcare: The Disparities Signify the Investment Opportunity
By Squire Servance, Founder & Managing Partner of Syridex Bio The evidence documenting vast disparities across the American healthcare system is plentiful – and at this point, it should surprise…
Read More